These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31173606)

  • 1. A bacterial secreted translocator hijacks riboregulators to control type III secretion in response to host cell contact.
    Kusmierek M; Hoßmann J; Witte R; Opitz W; Vollmer I; Volk M; Heroven AK; Wolf-Watz H; Dersch P
    PLoS Pathog; 2019 Jun; 15(6):e1007813. PubMed ID: 31173606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LcrQ Coordinates with the YopD-LcrH Complex To Repress
    Fei K; Yan H; Zeng X; Huang S; Tang W; Francis MS; Chen S; Hu Y
    mBio; 2021 Jun; 12(3):e0145721. PubMed ID: 34154409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNase-mediated reprogramming of Yersinia virulence.
    Meyer I; Volk M; Salto I; Moesser T; Chaoprasid P; Herbrüggen AS; Rohde M; Beckstette M; Heroven AK; Dersch P
    PLoS Pathog; 2024 Aug; 20(8):e1011965. PubMed ID: 39159284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YopN Is Required for Efficient Effector Translocation and Virulence in Yersinia pseudotuberculosis.
    Bamyaci S; Ekestubbe S; Nordfelth R; Erttmann SF; Edgren T; Forsberg Å
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
    Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gatekeeper of Yersinia type III secretion is under RNA thermometer control.
    Pienkoß S; Javadi S; Chaoprasid P; Nolte T; Twittenhoff C; Dersch P; Narberhaus F
    PLoS Pathog; 2021 Nov; 17(11):e1009650. PubMed ID: 34767606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the N-terminal secretor domain on YopD translocator function in Yersinia pseudotuberculosis type III secretion.
    Amer AA; Åhlund MK; Bröms JE; Forsberg Å; Francis MS
    J Bacteriol; 2011 Dec; 193(23):6683-700. PubMed ID: 21965570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type III secretion chaperone LcrH co-operates with YopD to establish a negative, regulatory loop for control of Yop synthesis in Yersinia pseudotuberculosis.
    Francis MS; Lloyd SA; Wolf-Watz H
    Mol Microbiol; 2001 Nov; 42(4):1075-93. PubMed ID: 11737648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Mechanism for Protein Delivery by the Type 3 Secretion System for Extracellularly Secreted Proteins.
    Tejeda-Dominguez F; Huerta-Cantillo J; Chavez-Dueñas L; Navarro-Garcia F
    mBio; 2017 Mar; 8(2):. PubMed ID: 28351918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic
    Morgan JM; Lam HN; Delgado J; Luu J; Mohammadi S; Isberg RR; Wang H; Auerbuch V
    Front Cell Infect Microbiol; 2018; 8():404. PubMed ID: 30524970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YopD self-assembly and binding to LcrV facilitate type III secretion activity by Yersinia pseudotuberculosis.
    Costa TR; Edqvist PJ; Bröms JE; Ahlund MK; Forsberg A; Francis MS
    J Biol Chem; 2010 Aug; 285(33):25269-84. PubMed ID: 20525687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RcsB positively regulates the Yersinia Ysc-Yop type III secretion system by activating expression of the master transcriptional regulator LcrF.
    Li Y; Hu Y; Francis MS; Chen S
    Environ Microbiol; 2015 Apr; 17(4):1219-33. PubMed ID: 25039908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation.
    Francis MS; Wolf-Watz H
    Mol Microbiol; 1998 Aug; 29(3):799-813. PubMed ID: 9723919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
    Edqvist PJ; Aili M; Liu J; Francis MS
    Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.
    Kwuan L; Adams W; Auerbuch V
    Infect Immun; 2013 Mar; 81(3):905-14. PubMed ID: 23297383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
    Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
    Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.